Loading stock data…
€71.12+0.38 (+0.54%)
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions.
Sanofi in the Healthcare sector is trading at €71.11 with a market capitalization of $90.3B. Wall Street consensus targets €93.56 (24 analysts), implying a +31.6% move over the next 12 months. The stock is currently near its 52-week low of €69.75, remaining 5.6% below its 200-day moving average. The Whystock Score of 45/100 suggests a balanced risk-reward profile.
| Metric (EUR) | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
| Total Revenue | €10.73B↓ | €13.17B↑ | €12.21B↑ | €11.24B↓ | €12.30B |
| Gross Profit | €7.74B↓ | €9.76B↑ | €8.45B↑ | €8.11B↓ | €9.28B |
| Operating Income | €1.71B↓ | €3.79B↑ | €1.63B↓ | €2.27B↓ | €2.38B |
| Net Income | €3.94B↑ | €2.80B↑ | -€801.00M↓ | €1.61B↑ | €343.00M |
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus...